Association of STAT4 polymorphism with severe renal insufficiency in lupus nephritis

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Bolin, Karin ^a   Sandling, Johanna K ^a   Zickert, Agneta ^b   Jönsen, Andreas ^c   Sjöwall, Christopher ^d   Svenungsson, Elisabet ^b   Bengtsson, Anders A ^c   Eloranta, Maija Leena ^a   Rönnblom, Lars ^a   Syvänen, Ann Christine ^a   Gunnarsson, Iva ^b   Nordmark, Gunnel ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

STAT4 PROTEIN; STAT4 PROTEIN, HUMAN;

ADULT; CASE CONTROL STUDY; CLINICAL TRIAL; COMPLICATION; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MULTICENTER STUDY; RENAL INSUFFICIENCY, CHRONIC; SEVERITY OF ILLNESS INDEX; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUPUS NEPHRITIS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RENAL INSUFFICIENCY, CHRONIC; SEVERITY OF ILLNESS INDEX; STAT4 TRANSCRIPTION FACTOR;

EID: 84893522542     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084450     Document Type: Article

References (47)

1. Ortega LM, Schultz DR, Lenz O, Pardo V, Contreras GN (2010) Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions. Lupus 19: 557-574.
2. Churg J, Bernstein J, Glassock RJ (1995) Lupus nephritis. Renal disease: classification and atlas of glomerular diseases. 2 ed. New York: Igaku-Shoin. pp. 151-155.
3. Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, et al. (2008) Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. Nô Englô Jô Med 358: 900-909. (Pubitemid 351397089)
4. Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, et al. (2007) STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. Nô Englô Jô Med 357: 977-986. (Pubitemid 47367077)
5. Sigurdsson S, Nordmark G, Goring HH, Lindroos K, Wiman AC, et al. (2005) Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Amô Jô Hum Genet 76: 528-537. (Pubitemid 40250533)
6. Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, et al. (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 41: 1228-1233.
7. Ramos PS, Brown EE, Kimberly RP, Langefeld CD (2010) Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis. Semin Nephrol 30: 164-176.
8. Alonso-Perez E, Suarez-Gestal M, Calaza M, Ordi-Ros J, Balada E, et al. (2012) Further evidence of subphenotype association with systemic lupus erythematosus susceptibility loci: a European cases only study. PLoS One 7: e45356.
9. Bates JS, Lessard CJ, Leon JM, Nguyen T, Battiest LJ, et al. (2009) Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations. Genes Immun 10: 470-477.
10. Jonsen A, Gunnarsson I, Gullstrand B, Svenungsson E, Bengtsson AA, et al. (2007) Association between SLE nephritis and polymorphic variants of the CRP and FcgammaRIIIa genes. Rheumatology (Oxford) 46: 1417-1421. (Pubitemid 47317086)
11. Kim-Howard X, Maiti AK, Anaya JM, Bruner GR, Brown E, et al. (2010) ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry. Ann Rheum Dis 69: 1329-1332.
12. Malafronte P, Vieira JM, Jr., Pereira AC, Krieger JE, Barros RT, et al. (2010) Association of the MCP-1 -2518 A/G polymorphism and no association of its receptor CCR2 -64 V/I polymorphism with lupus nephritis. Jô Rheumatol 37: 776-782.
13. Prokunina L, Gunnarsson I, Sturfelt G, Truedsson L, Seligman VA, et al. (2004) The systemic lupus erythematosus-associated PDCD1 polymorphism PD1.3A in lupus nephritis. Arthritis Rheum 50: 327-328. (Pubitemid 38084318)
14. Sanchez E, Nadig A, Richardson BC, Freedman BI, Kaufman KM, et al. (2011) Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann Rheum Dis 70: 1752-1757.
15. Santos MJ, Fernandes D, Capela S, da Silva JC, Fonseca JE (2011) Interleukin-6 promoter polymorphism -174 G/C is associated with nephritis in Portuguese Caucasian systemic lupus erythematosus patients. Clin Rheumatol 30: 409-413.
16. Sigurdsson S, Nordmark G, Garnier S, Grundberg E, Kwan T, et al. (2008) A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5. Hum Mol Genet 17: 2868-2876.
17. Suresh S, Demirci FY, Jacobs E, Kao AH, Rhew EY, et al. (2009) Apolipoprotein H promoter polymorphisms in relation to lupus and lupus-related phenotypes. Jô Rheumatol 36: 315-322.
18. Taylor KE, Remmers EF, Lee AT, Ortmann WA, Plenge RM, et al. (2008) Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus. PLoS Genet 4: e1000084.
19. Wang C, Ahlford A, Jarvinen TM, Nordmark G, Eloranta ML, et al. (2013) Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations. Eurô Jô Hum Genet 21:994-999.
20. Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, et al. (2007) TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. Nô Englô Jô Med 357: 1199-1209. (Pubitemid 47443179)
21. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1277. (Pubitemid 13221242)
22. K/DOQI clinical practice guidelines for chronic kidney disease:evaluation, classification, and stratification (2002). Am J Kidney Dis 39: S1-266.
23. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Amô Jô Hum Genet 81: 559-575. (Pubitemid 47330214)
24. Kaplan MH (2005) STAT4: A critical regulator of inflammation in vivo. Immunol Res 31: 231-242.
25. Iwata Y, Furuichi K, Kaneko S, Wada T (2011) The role of cytokine in the lupus nephritis. Jô Biomed Biotechnol 2011: 594809.
26. Zickert A, Amoudruz P, Rönnelid J, Malmström V, Gunnarsson I (2011) Serum cytokines in lupus nephritis, levels of IL-17 and IL-23 in association to histopathology and response to treatment. Arthritis Rheum 63: S648.
27. Crispin JC, Oukka M, Bayliss G, Cohen RA, Van Beek CA, et al. (2008) Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. Jô Immunol 181: 8761-8766.
28. Kariuki SN, Kirou KA, MacDermott EJ, Barillas-Arias L, Crow MK, et al. (2009) Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo. Jô Immunol 182: 34-38.
29. Rönnblom L, Alm GV, Eloranta ML (2011) The type I interferon system in the development of lupus. Semin Immunol 23: 113-121.
30. Morimoto S, Nakano S, Watanabe T, Tamayama Y, Mitsuo A, et al. (2007) Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production. Rheumatology (Oxford) 46: 1083-1086. (Pubitemid 47050608)
31. Sandling JK, Garnier S, Sigurdsson S, Wang C, Nordmark G, et al. (2011) A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE. Eurô Jô Hum Genet 19: 479-484.
32. Chung SA, Taylor KE, Graham RR, Nititham J, Lee AT, et al. (2011) Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production. PLoS Genet 7: e1001323.
33. Taylor KE, Chung SA, Graham RR, Ortmann WA, Lee AT, et al. (2011) Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes. PLoS Genet 7: e1001311.
34. Kelly JA, Kelley JM, Kaufman KM, Kilpatrick J, Bruner GR, et al. (2008) Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes Immun 9: 187-194. (Pubitemid 351584185)
35. Reddy MV, Velazquez-Cruz R, Baca V, Lima G, Granados J, et al. (2007) Genetic association of IRF5 with SLE in Mexicans: higher frequency of the risk haplotype and its homozygozity than Europeans. Hum Genet 121: 721-727. (Pubitemid 46916971)
36. Shin HD, Sung YK, Choi CB, Lee SO, Lee HW, et al. (2007) Replication of the genetic effects of IFN regulatory factor 5 (IRF5) on systemic lupus erythematosus in a Korean population. Arthritis Res Ther 9: R32.
37. Qin L, Lv J, Zhou X, Hou P, Yang H, et al. (2010) Association of IRF5 gene polymorphisms and lupus nephritis in a Chinese population. Nephrology (Carlton) 15: 710-713.
38. Sigurdsson S, Goring HH, Kristjansdottir G, Milani L, Nordmark G, et al. (2008) Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum Mol Genet 17: 872-881. (Pubitemid 351368993)
39. Kawasaki A, Ito S, Furukawa H, Hayashi T, Goto D, et al. (2010) Association of TNFAIP3 interacting protein 1, TNIP1 with systemic lupus erythematosus in a Japanese population: a case-control association study. Arthritis Res Ther 12: R174.
40. Tsao BP (2003) The genetics of human systemic lupus erythematosus. Trends Immunol 24: 595-602.
41. Yang W, Zhao M, Hirankarn N, Lau CS, Mok CC, et al. (2009) ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai. Hum Mol Genet 18: 2063-2070.
42. Clendenning M, Senter L, Hampel H, Robinson KL, Sun S, et al. (2008) A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome. Jô Med Genet 45: 340-345. (Pubitemid 351839474)
43. Lenz G, Davis RE, Ngo VN, Lam L, George TC, et al. (2008) Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319: 1676-1679. (Pubitemid 351432507)
44. Lofstrom B, Backlin C, Sundstrom C, Ekbom A, Lundberg IE (2007) A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study. Ann Rheum Dis 66: 1627-1632. (Pubitemid 350205452)
45. Jacob CO, Zhu J, Armstrong DL, Yan M, Han J, et al. (2009) Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sciô Uô Sô A 106: 6256-6261.
46. Contreras G, Pardo V, Cely C, Borja E, Hurtado A, et al. (2005) Factors associated with poor outcomes in patients with lupus nephritis. Lupus 14: 890-895. (Pubitemid 41736370)
47. Svenungsson E, Gustafsson J, Leonard D, Sandling J, Gunnarsson I, et al. (2010) A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus. Ann Rheum Dis 69: 834-840.